The Effect of Crystalloids and Colloids on Visceral Blood Flow
The Effects of Balanced and Unbalanced Crystalloids and Colloids on Serum Biochemistry and Visceral Blood Flow: A Two Phase, Double Blind, Randomised Crossover Study
2 other identifiers
interventional
25
1 country
1
Brief Summary
Patients often require fluid replacement during and after an operation. This is usually given through veins in the arm using an intravenous cannula and doctors have traditionally used fluid containing sodium chloride (saline). However accumulating evidence suggests that large infusions of saline are associated with adverse physiological effects including acidification of the blood and a rise in potassium and chloride levels. Studies in animals have shown that high levels of chloride in the blood and excess saline can cause blood vessels in the kidney to constrict leading possibly to a decrease in kidney function. Improvement in acid-base balance and kidney function may be observed with balanced solutions containing constituents that are more closely matched to the body's own fluid composition. However, little is known about the physiological effects of these solutions as they have only recently been developed. Magnetic resonance imaging (MRI) is a radiological modality which can now assess blood flow and supply of the kidney noninvasively without the need for the injection of radiological dyes known as contrast agents. This is now of major importance due to the possible adverse effects of MRI contrast agents leading to Nephrogenic Systemic Fibrosis (NSF), a progressive disease which has been observed in some kidney patients after receiving 'gadolinium based' contrast agents. This has therefore led to increased interest and demand for noncontrast based imaging methods. In this study we aim to compare the effects of balanced versus unbalanced fluid infusions in healthy human volunteers: We will aim to measure:
- 1.Blood biochemical composition and acidity
- 2.Kidney function and supply as measured by dynamic MRI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Mar 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 15, 2010
CompletedFirst Posted
Study publicly available on registry
March 16, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJune 1, 2011
May 1, 2011
1 year
March 15, 2010
May 31, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary end point of each phase of this study will be a 6 mmol difference in serum chloride concentration after infusion of the balanced and unbalanced crystalloids and colloids.
Phase A: Times 0, 60, 90, 120, 180 and 240 min and Phase B: Times 0, 30, 60, 120, 180 and 240 min
Secondary Outcomes (1)
Changes in blood volume, renal and superior mesenteric arterial blood flow and vessel diameter.
Phase A: Times 0, 60, 90, 120, 180 and 240 min and Phase B: Times 0, 30, 60, 120, 180 and 240 min
Study Arms (4)
Phase A1: Plasmalyte
ACTIVE COMPARATORPlasmalyte
Phase A2: 0.9% Saline
ACTIVE COMPARATOR0.9% Saline
Phase B1: PlasmaVolume
ACTIVE COMPARATORPlasmaVolume
Phase B2: Voluven
ACTIVE COMPARATORVoluven
Interventions
Eligibility Criteria
You may qualify if:
- Healthy
- Male
- Aged between 18 and 40 years
- Weight between 65 and 80 kilograms
- Able to give informed consent
You may not qualify if:
- Chronic medical conditions
- Use of any regular medications
- History of substance abuse
- Known hypersensitivity to study infusion fluids
- Contraindications to MRI scanning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brain and Body MRI Centre, University of Nottingham
Nottingham, Nottinghamshire, NG7 2RD, United Kingdom
Related Publications (1)
Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012 Jul;256(1):18-24. doi: 10.1097/SLA.0b013e318256be72.
PMID: 22580944DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dileep Lobo, MBBS MD FRCS
University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 15, 2010
First Posted
March 16, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
June 1, 2011
Record last verified: 2011-05